To measure the clinical effect of adding a whole cell pertussis component to diphtherial
tetanus vaccine (DT) given as a pre-school booster, 190 children aged 4–5 years were …

OBJECTIVES: The aim of this study was to evaluate the safety and immunogenicity of DTPa–
HBV and Hib vaccines given mixed or separately to 360 healthy infants at 2, 4, and 6 months …

Pertussis is one of the only vaccine-preventable diseases with increasing incidence in the
United States. The incidence of pertussis infection in adolescents is a growing concern; it …

Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

The reactogenicity and immunogenicity of a tetravalent diphtheria-tetanus-acellular
pertussis-hepatitis B (DTPa-HB) vaccine (SmithKline Beecham) were studied in 565 infants …

Vaccination against diphtheria, tetanus, and pertussis (DTP) has achieved great success in
infants and younger children in China. However, pertussis booster vaccination in older …

In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …

Adult pertussis vaccination is increasingly recommended to control pertussis in the
community. However, there is little data on the duration and kinetics of immunity to pertussis …

Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …

Data from two Swedish pertussis vaccine trials with various combination vaccines were used
to compare anti-diphtheria antitoxin concentrations over time between different vaccines …